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Abstract
Age-related hearing impairment (ARHI), one of the most common sensory disorders, can be
mitigated, but not cured or eliminated. To identify genetic influences underlying ARHI, we con-
ducted a genome-wide association study of ARHI in 6,527 cases and 45,882 controls among
the non-Hispanic whites from the Genetic Epidemiology Research on Adult Health and Aging
(GERA) cohort. We identified two novel genome-wide significant SNPs: rs4932196 (odds
ratio = 1.185, p = 4.0x10-11), 52Kb 3’ of ISG20, which replicated in a meta-analysis of the
other GERA race/ethnicity groups (1,025 cases, 12,388 controls, p = 0.00094) and in a UK
Biobank case-control analysis (30,802 self-reported cases, 78,586 controls, p = 0.015); and
rs58389158 (odds ratio = 1.132, p = 1.8x10-9), which replicated in the UK Biobank (p =
0.00021). The latter SNP lies just outside exon 8 and is highly correlated (r2 = 0.96) with the
missense SNP rs5756795 in exon 7 of TRIOBP, a gene previously associated with prelingual
nonsyndromic hearing loss. We further tested these SNPs in phenotypes from audiologist
notes available on a subset of GERA (4,903 individuals), stratified by case/control status, to
construct an independent replication test, and found a significant effect of rs58389158 on
speech reception threshold (SRT; overall GERA meta-analysis p = 1.9x10-6). We also tested
variants within exons of 132 other previously-identified hearing loss genes, and identified
two common additional significant SNPs: rs2877561 (synonymous change in ILDR1, p =
6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT
(p = 0.00019) and speech discrimination score (SDS; p = 0.0019); and rs9493627 (missense
change in EYA4, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA
groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and sugges-
tive result for SDS (p = 0.081). Large cohorts with GWAS data and electronic health records
may be a useful method to characterize the genetic architecture of ARHI.
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Author Summary
Age-related hearing impairment (ARHI) is one of the most common sensory disorders.
While ARHI effects can be mitigated with current technologies, it cannot be cured or elim-
inated. It is thus hoped that identification of genetic influences on ARHI may one day lead
to curative therapies. Towards this goal, the current study utilized electronic health record
data from non-Hispanic whites in the Genetic Epidemiology Research on Adult Health
and Aging (GERA) cohort to conduct a genome-wide association study of ARHI, and
tested the significant variants for replication in other GERA race/ethnicity groups, inde-
pendent GERA phenotypes, and self-reportedARHI from the UK Biobank.We discovered
two genome-wide significant SNPs. The first was novel and near ISG20. The second was in
TRIOBP, a gene previously associated with prelingual nonsyndromic hearing loss. Moti-
vated by our TRIOBP results, we also looked at exons in known hearing loss genes, and
identified two additional SNPs, rs2877561 in ILDR1 and rs9493672 in EYA4 (at a signifi-
cance threshold adjusted for number of SNPs in those regions). These results suggest that
large cohorts with GWAS data and electronic health records may be a usefulmethod to
characterize the genetic architecture of ARHI.
Introduction
Age-related hearing impairment (ARHI), or presbycusis, is one of the most common sensory
impairments [1,2], affecting 25% of individuals over age 65 and 50% of individuals over age 80
[3]. ARHI impacts speech understanding,makes it much more difficult to communicate, and
leads to an overall lower quality of life [4]. The effects of ARHI can be mitigated by amplifica-
tion devices and assistive listening devices, but it is not curable and the effects cannot be
completely eliminated. The best hope for cure lies in identifying all the physiologic and envi-
ronmental factors contributing to ARHI and developing interventions that address these risks.
There are a number of contributing factors to ARHI, including early noise exposure, medica-
tion history, and genetics [1,5–11]. It is hoped that by identifying the genetic basis of ARHI,
targeted therapies can be developed to mitigate this risk.
ARHI has a clear genetic contribution; in a study of twins, hearing loss after age 64 was
shown to have a heritability of 47% [12]; another study based on self-reported hearing loss in
twins over age 75 reported a heritability of 40% [13]. During the past decade, genome-wide
association studies (GWAS) have tried to uncover risk variants for ARHI, but no genome-wide
significant or suggestive loci have been found that have been successfully replicated [3,14–16].
One study was based on 846 ARHI cases and 846 controls [3], while three other studies used
principal components (PCs) of hearing impairment thresholds at several frequencies in 3,417
European individuals [15], 2,161 Belgian individuals [14], and 352 Finnish Saami individuals
[16]. Fransen et al. attempted to replicate suggestive SNPs from previous papers, but failed to
do so [14]. Of note, the sample sizes in these studies are smaller than those used to study other
complex traits [17].
It is clear from these prior studies that much larger sample sizes are needed to better delin-
eate the genetic factors associated with ARHI. Towards this goal, we utilized 6,527 non-His-
panic white ARHI cases and 45,882 controls identified from electronic health records (EHR) of
members of the Kaiser Permanente Northern California (KPNC) health care system who par-
ticipated in the Kaiser Permanente Research Program on Genes, Environment, and Health
(RPGEH) Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort for
Genome-Wide Study of Age-Related Hearing Impairment
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discovery. Loci with genome-wide significance identified in the GERA non-Hispanic whites
were then tested for independent replication in 1,025 Latino, East Asian, and African American
GERA cases and 12,388 controls, in addition to 30,802 UK Biobank self-reported cases and
78,586 controls. We also tested for replication in two related measured quantitative traits—
speech discrimination score (SDS) and speech recognition threshold (SRT), stratified by case/
control status, to construct independent tests. These measures were only available on a subset
of the GERA individuals. Additionally, we assessed replication of previously-described sub-
genome-wide significant loci in the GERA cohort. Motivated by our GWAS results, we also
examined the GWAS results at known hearing loss genes at reduced significance thresholds
adjusted for the proportion of the genome being tested to account for lack of power in these
regions. Finally, we looked at array-based heritability in the GERA non-Hispanic whites.
Results
The GERA cohort
The multi-ethnic GERA cohort participants in this study were part of the Kaiser Permanente
Research Program on Genes, Environment, and Health (RPGEH), which has been described in
detail [18,19]. Briefly, participants were an average of 62.9 years old (SD = 13.8) at sample col-
lection, with an average length of membership of 23.5 years in Kaiser Permanente Northern
California, comprehensive EHR, survey (five pages including information on demographic fac-
tors, behaviors, and self-reported health, but no questions on hearing), and genome-wide geno-
typing data.
We used as our discovery cohort the largest GERA subgroup of non-Hispanic whites (6,527
cases, 45,882 controls), with our replication cohort in GERA consisting of Latinos/East Asians/
African Americans with 481/398/146 cases and 5,215/5,040/2,133 controls, respectively (work-
flow of GERA phenotyping in Fig 1A). Compared to the controls, the cases were more often
male and older (Table 1). There were 4,903 total individuals (4,231 non-Hispanic white, 298
Latino, 249 East Asian, and 125 African American) for whom audiologist notes were available
(the majority in cases), and could be used to derive quantitative measures of speech recognition
threshold (SRT) and speech discrimination score (SDS), as well as history of noise exposure
(Table 1).
Within each race/ethnicity group, we also tested ancestry principal components (PCs) [18]
for association with ARHI, adjusting for the potential confounders of diabetes, hypertension,
and osteoporosis. In non-Hispanic whites, we found a significant increase in ARHI in those
with northwestern vs. southeastern European ancestry (p = 9.2×10−10), but it explained very lit-
tle of the variance (0.12%). No significant associations were found in Latinos, East Asians, or
African Americans, but we had less statistical power in these groups.
GWAS results
In the discovery stage of the GWAS, we analyzed the GERA non-Hispanic whites (workflow of
genotyping of GERA and replication cohorts in Fig 1B and 1C and of analysis in Fig 1D, Man-
hattan plot in Fig 2, Q-Q plot in S1 Fig). The genomic inflation factor was reasonable for the
sample size being tested (genotyped λ = 1.037, imputed λ = 1.053) [20]. We detected two novel
genome-wide significant (p<5x10-8) loci associated with ARHI.
The first SNP, rs4932196, was at 15q26, b37 position 89,253,268 (GERA non-Hispanic
white odds ratio (OR) = 1.185, p = 4.0x10-11, frequency of the risk allele = 0.810, zoomed in
plot of locus in Fig 3A), 52kb 3’ of ISG20 and 638kb 5’ of ACAN. There were several genome-
wide significant and suggestive typed SNPs around the top (imputed) SNP–rs6496519,
p = 1.3x10-10, call rate (CR) = 99.9%, r2 = 0.953; rs35701059, p = 7.8x10-9, CR = 99.9%, r2 =
Genome-Wide Study of Age-Related Hearing Impairment
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0.858; rs11073807, p = 1.5x10-7, CR = 99.8%, r2 = 0.389 –giving strong evidence that the signal
was not driven by genotyping error. Further, the same top SNP was replicated in the meta-
analysis of the GERA Latinos, East Asians, and African Americans (OR = 1.192, p = 0.00094,
Fig 1. Study design. (A) GERA genotyping, (B) GERA phenotyping, (C) UK Biobank replication cohort, and (D) analysis. DX, diagnosis.
doi:10.1371/journal.pgen.1006371.g001
Genome-Wide Study of Age-Related Hearing Impairment
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one-sided for all replication tests since the hypothesis is that the effect is in the same direction),
and was in the same direction in each individual group (Table 2). The same SNP was also repli-
cated in UK Biobank individuals (OR = 1.028, p = 0.015) although that analysis was based on a
self-reported cross-sectional phenotype that was different from the GERA individuals (see
Methods). Meta-analysis of all four GERA race/ethnicity groups together gave an OR = 1.186,
Table 1. Characteristics of age-related hearing impairment (ARHI) cases and controls in the GERA cohort. Note that speech reception threshold
(SRT) and speech discrimination score (SDS) were only available on a small portion of the cohort. For dichotomous variables, N (% of non-missing), and for
continuous variables, mean (sd), unless otherwise indicated.
Non-Hispanic white Latino East Asian African American
Case Control Case Control Case Control Case Control
ARHI 6527 (12.5%) 45882 481 (8.4%) 5215 398 (7.3%) 5040 146 (6.4%) 2133
Female 3087 (47.3%) 28454 (62.0%) 212 (44.1%) 3312 (63.5%) 156 (39.2%) 3047 (60.5%) 73 (50.0%) 1277 (59.9%)
Age 75.1 (9.1) 67.0 (13.0) 73.2 (9.5) 60.5 (14.1) 74.6 (9.5) 61.1 (13.9) 75.1 (9.7) 64.9 (13.2)
SRT N 3738 (57.3%) 424 (0.9%) 248 (51.6%) 46 (0.9%) 214 (53.8%) 28 (0.6%) 96 (65.8%) 28 (1.3%)





10.0 [5.0–15.0] 32.5 [25.0–
42.5]
7.5 [5.0–12.5] 35.0 [25.0–
47.5]
10.0 [7.2–13.1] 35.0 [25.0–
42.5]
10.6 [10.0–15.0]
SDS N 3793 (58.1%) 428 (0.9%) 250 (52.0%) 47 (0.9%) 218 (54.8%) 28 (0.6%) 97 (66.4%) 28 (1.3%)



















Noise N 3826 (58.6%) 429 (0.9%) 254 (52.8%) 47 (0.9%) 220 (55.3%) 29 (0.6%) 97 (66.4%) 28 (1.3%)
Noise 2213 (57.8%) 194 (45.2%) 153 (60.2%) 21 (44.7%) 129 (58.6%) 11 (37.9%) 54 (55.7%) 10 (35.7%)
doi:10.1371/journal.pgen.1006371.t001
Fig 2. ARHI Manhattan plot in GERA non-Hispanic whites. SNPs meeting genome-wide significance (p<5x10-8) are above the red line. The circles
indicate genotyped SNPs, and the triangles indicate imputed SNPs. Dark colored points indicate previously-described sub-threshold suggestive hits, and
light colored points are within 0.5Mb of the actual SNP (blue imputed, green genotyped).
doi:10.1371/journal.pgen.1006371.g002
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p = 2.8x10-13, with no evidence of heterogeneity (I2 = 0, p = 0.82); we did not include the UK
Biobank in the meta-analysis due to differences in the phenotype. On the subset of the cohort
that had audiologist notes, the SNP association with overall transformed SRT was suggestive
(β = 0.043, higher values indicate worse hearing, p = 0.039, stratified by case/control status for
Fig 3. Zoomed in locus plots in GERA non-Hispanic whites. The circles indicate genotyped SNPs, and the triangles indicate imputed SNPs. The blue
line is the recombination map, which is given according to the y-axis on the right hand side of the plot. The color scheme identifies the correlation to the lead
SNP in the locus (colorbar on the left). Larger points indicate SNPs in exons. Genome-wide significant SNPs are given in (A) rs4932196 and (B)
rs58389158, and SNPs identified in hearing loss gene exons in (C) rs2877561 and (D) rs9493627.
doi:10.1371/journal.pgen.1006371.g003
Genome-Wide Study of Age-Related Hearing Impairment
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an independent test, seeMethods), and the association with overall SDS less so (β = 0.023,
higher values indicate worse hearing, p = 0.13), although both were in the same direction as the
ARHI phenotype (Table 2).
The second SNP, rs58389158, is an imputed indel at 22q13.1, b37 position 38,128,283
(GERA non-Hispanic white OR = 1.132, p = 1.8x10-9, frequency of the risk allele = 0.421,
zoomed in plot of locus in Fig 3B), in an intron of the long form of TRIOBP (Table 2). The sig-
nal initially appeared to be driven by one genotyped SNP, rs5750477 (p = 1.8x10-8), with a
lower CR = 90.8%, and r2 = 0.77 with rs58389158. Although the CR was low, genotype cluster
plots of the SNP showed well separated clusters with only modest overlap. However, to ensure
Table 2. Genome-wide significant GWAS SNPs. The genotype is coded for the risk increasing allele, which is the first one mentioned (e.g., T in T/A). The
discovery test of ARHI in GERA non-Hispanic whites was two-sided#, and all replication tests were one-sided. There are no estimates for African American
cases SDS/SRT, as the sample size was too small. OR, odds ratio (for case/control phenotypes); Effect, effect size estimate (for SDS/SRT phenotypes);
Freq, frequency of the risk increasing allele; SRT, speech reception threshold; SDS, speech discrimination score.
rs4932196 (T/A)– 52kb 3’ of
ISG20, 638kb 5’ ACAN
rs58389158 (T/TA)– 5773bp 3’
exon 7, 1021 bp 5’ exon 8 of
long form of TRIOBP
Phenotype Group Freq OR/
Effect
P rinfo2 Freq OR/
Effect
P rinfo2
ARHI ICD-9 case/control GERA non-Hispanic white# 0.810 1.185 4.0x10-
11
0.99 0.421 1.132 1.8x10-
9
0.90
GERA Latino 0.726 1.147 0.047 0.98 0.369 1.039 0.30 0.99
GERA East Asian 0.525 1.215 0.0082 0.95 0.567 1.108 0.11 0.92
GERA African American 0.930 1.504 0.079 0.98 0.221 0.850 0.86 0.97
GERA Latino, East Asian, and African
American replication meta-analysis
- 1.192 0.00094 - - 1.041 0.22 -
ARHI case/control by self-report UK Biobank 0.804 1.028 0.015 1.00 0.459 1.036 0.00021 1.00
Cases SRT, modeled as sqrt(SRT),
higher is worse hearing
GERA non-Hispanic white 0.832 0.030 0.23 0.99 0.433 0.050 0.13 0.99
GERA Latino 0.707 0.299 0.0079 0.98 0.345 0.248 0.019 0.98
GERA East Asian 0.639 0.048 0.39 0.95 0.575 0.026 0.42 0.95
GERA African American - - - 0.98 - - - 0.98
GERA Meta-analysis of all - 0.056 0.070 - - 0.059 0.029 -
Controls SRT GERA non-Hispanic white 0.835 -0.006 0.57 0.99 0.431 0.125 1.8x10-
6
0.99
GERA Latino 0.779 0.227 0.013 0.98 0.369 -0.181 0.98 0.98
GERA East Asian 0.578 0.145 0.078 0.95 0.550 0.218 0.015 0.95
GERA African American 0.946 0.301 0.21 0.98 0.206 0.243 0.12 0.98
GERA Meta-analysis of all - 0.034 0.14 - - 0.109 5.7x10-
6
-
Overall SRT GERA Meta-analysis of all - 0.043 0.039 - - 0.090 1.9x10-
6
-
Cases SDS, modeled as log(100-SDS
+1), higher is worse hearing
GERA non-Hispanic white 0.829 0.066 0.037 0.99 0.433 0.019 0.26 0.99
GERA Latino 0.702 0.041 0.36 0.98 0.339 -0.098 0.85 0.98
GERA East Asian 0.637 0.322 0.020 0.95 0.579 0.271 0.021 0.95
GERA African American - - - 0.98 - - - 0.98
GERA Meta-analysis of all - 0.076 0.013 - - 0.019 0.24 -
Controls SDS GERA non-Hispanic white 0.830 -0.030 0.84 0.99 0.430 0.013 0.28 0.99
GERA Latino 0.778 0.122 0.081 0.98 0.371 -0.128 0.95 0.98
GERA East Asian 0.560 0.100 0.15 0.95 0.557 -0.001 0.50 0.95
GERA African American 0.947 -0.230 0.87 0.98 0.205 0.103 0.30 0.98
GERA Meta-analysis of all - -0.009 0.63 - - 0.002 0.46 -
Overall SDS GERA Meta-analysis of all - 0.023 0.13 - - 0.009 0.30 -
doi:10.1371/journal.pgen.1006371.t002
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the associationwas not driven by genotyping artifacts, we removed rs5750477 from the analysis
and re-imputed rs58389158. The SNP did not impute quite as well as previously (r2 = 0.75 as
opposed to r2 = 0.90 with the SNP), and had a slightly less significant p-value (p = 1.0x10-7),
which likely reflects reduced power due to poorer imputation accuracy. Although the SNP did
not show evidence of association in the replication meta-analysis of the GERA Latinos, East
Asians, and African Americans (OR = 1.041, p = 0.22), the effect was in the same direction. In
addition, the SNP association was replicated in the UK Biobank data (OR = 1.036, p =0.00021),
and was strongly associated with transformed SRT (β = 0.090, p = 1.9x10-6). For SDS, the SNP
effect was in the same direction but not statistically significant (β = 0.009, p = 0.30).
We also looked for a sex difference in the OR of ARHI with the top SNPs in the GERA non-
Hispanic whites. There was no significant evidence of heterogeneity (rs4932196 I2 = 55.4,
p = 0.13; rs58389158 I2 = 66.9, p = 0.082) betweenmales and females (rs4932196 ORmale =
1.143, ORfemale = 1.234; rs58389159 ORmale = 1.166, ORfemale = 1.085). Also, no additional loci
were identified in sex-specificGWAS analyses. Finally, no additional SNPs at the two novel
loci were discovered in a conditional analysis including the top two SNPs.
Testing previously reported ARHI associations
We tested 58 previously reported sub-genome-wide significant SNPs [3,14–16] for replication
in GERA non-Hispanic whites. No SNP reached a Bonferroni corrected threshold of 0.00086,
with only three SNPs being of marginal significance 0.01<p<0.05 (S1 Table).
ARHI associations at previously identified hearing loss genes
Motivated by our TRIOBP results, we also examined SNPs from our GWAS results in 132
knownMendelian hearing loss genes [21] in GERA non-Hispanic whites at a reduced signifi-
cance threshold adjusted for the proportion of the genome being tested to account for potential
lack of power in these regions. For each of the genes, we looked separately at exonic SNPs, spe-
cifically non-synonymous and synonymous coding changes, and then SNPs that were eQTLs
for that gene in any GTeX tissue (no human auditory tissues available; each highlighted in S2
Fig) [22]. We identified two significant SNPs: rs2877561 in ILDR1 (p = 6.2x10-5, Table 3, Fig
3C; Bonferroni α level for synonymous changes 9.3x10-5) and rs9493627 in EYA4 (p = 0.00011,
Table 3, Fig 3D; Bonferroni α level for nonsynonymous changes 0.00025). The first SNP,
rs2877561, replicated in the UK Biobank (p = 0.00057), had a non-significant but consistent
effect in the other GERA groups (p = 0.42), and was significant for both GERA SRT (p =
0.00019) and SDS (p = 0.0019). The second SNP, rs9493627, replicated in the UK Biobank
(p = 0.0095), the other GERA race/ethnicity groups (p = 0.0080), and was marginally signifi-
cant and in the correct direction for SRT (p = 0.041) and suggestively so for SDS (p = 0.081).
Age at onset
We also examined the age of onset distributions for the four identified SNPs (empirical cumu-
lative distribution functions, S3 Fig). For three of the SNPs, there was no pattern towards ear-
lier onset for the predisposing allele (rs4932196 p = 0.24, rs58389158 p = 0.75, rs2877561
p = 0.97); however, for SNP rs9493627 in EYA4, there was a suggestive trend (p = 0.044)
towards earlier onset with the number of risk alleles.
Heritability and variance explained by ARHI associated SNPs
The heritability explained by all of the genome-wide SNPs was estimated to be a somewhat
modest 8.7% (95% CI = 2.9%-14.4%). This estimate depends on the assumed prevalence of
Genome-Wide Study of Age-Related Hearing Impairment
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ARHI in the cohort; we assessed the sensitivity to this assumption, finding that the heritability
estimate was 10.7% (95% CI = 3.6%-17.8%) when using twice the prevalence.We note that this
is below previous estimates from twin studies [12,13], though we discuss later why this may be
an underestimate (see Discussion). In addition, the amount of variance explained by the four
SNPs found here was very small at a combined 0.43% (rs49321 0.18%, rs58389185 0.12%,
rs2877561 0.064%, rs9493627 0.056%) suggesting there are still many more loci to be found.
Discussion
In this large cohort comprised of members of KPNC, we identified two novel SNP associations
in the GERA non-Hispanic whites that showed replication in at least two of three subsequent
Table 3. SNPs identified in candidate gene exon analysis. The genotype is coded for the risk increasing allele, which is the first one mentioned (e.g., A
in A/C). The discovery test of ARHI in GERA non-Hispanic whites was two-sided#, and all replication tests were one-sided. There are no estimates for African
American cases SDS/SRT, as the sample size was too small. OR, odds ratio (for case/control phenotypes); Effect, effect size estimate (for SDS/SRT pheno-
types); Freq, frequency of the risk increasing allele; SRT, speech reception threshold; SDS, speech discrimination score.
rs2877561 (A/C)–exon 2 all
transcripts, synonymous,
ILDR1
rs9493627 (A/G)–exon 11 of
NM_172105 & NM_004100,
exon 10 of NM_172103,
missense, EYA4
Phenotype Group Freq OR/
Effect
P rinfo2 Freq OR/
Effect
P rinfo2
ARHI ICD-9 case/control GERA non-Hispanic white# 0.281 1.090 6.2x10-5 0.98 0.317 1.083 0.00011 1.00
GERA Latino 0.347 0.930 0.16 0.99 0.313 1.217 0.0037 1.00
GERA East Asian 0.092 1.099 0.26 0.96 0.338 1.009 0.46 1.00
GERA African American 0.190 1.141 0.20 0.96 0.505 1.176 0.095 1.00
GERA Latino, East Asian, and African
Americans replication meta-analysis
- 0.988 0.42 - - 1.129 0.0080 -
ARHI case/control by self-report UK Biobank 0.271 1.037 0.00057 0.98 0.319 1.025 0.0095 1.00
Cases SRT, modeled as sqrt(SRT),
higher is worse hearing
GERA non-Hispanic white 0.301 0.089 0.0055 0.98 0.329 0.033 0.16 1.00
GERA Latino 0.334 -0.096 0.75 0.99 0.372 -0.140 0.89 1.00
GERA East Asian 0.070 -0.187 0.71 0.96 0.443 0.054 0.32 1.00
GERA African American - - - 0.96 - - - 1.00
GERA Meta-analysis of all - 0.077 0.012 - - 0.021 0.24 -
Controls SRT GERA non-Hispanic white 0.283 0.058 0.027 0.98 0.332 0.041 0.072 1.00
GERA Latino 0.282 0.275 0.0011 0.99 0.350 -0.075 0.75 1.00
GERA East Asian 0.094 0.189 0.11 0.96 0.312 0.157 0.056 1.00
GERA African American 0.196 -0.279 0.93 0.96 0.546 0.137 0.27 1.00
GERA Meta-analysis of all - 0.076 0.0032 - - 0.044 0.046 -
Overall SRT GERA Meta-analysis of all - 0.076 0.00019 - - 0.034 0.041 -
Cases SDS, modeled as log(100-SDS
+1), higher is worse hearing
GERA non-Hispanic white 0.303 0.045 0.065 0.98 0.332 -0.015 0.70 1.00
GERA Latino 0.344 0.035 0.39 0.99 0.368 -0.209 0.98 1.00
GERA East Asian 0.078 -0.135 0.65 0.96 0.449 0.318 0.0035 1.00
GERA African American - - - 0.96 - - - 1.00
GERA Meta-analysis of all - 0.044 0.070 - - -0.012 0.67 -
Controls SDS GERA non-Hispanic white 0.284 0.048 0.027 0.98 0.330 0.062 0.0042 1.00
GERA Latino 0.294 0.232 0.0033 0.99 0.338 -0.099 0.84 1.00
GERA East Asian 0.097 0.054 0.37 0.96 0.315 0.019 0.42 1.00
GERA African American 0.202 -0.091 0.73 0.96 0.542 0.214 0.14 1.00
GERA Meta-analysis of all - 0.059 0.0060 - - 0.048 0.015 -
Overall SDS GERA Meta-analysis of all - 0.053 0.0019 - - 0.024 0.081 -
doi:10.1371/journal.pgen.1006371.t003
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analyses: meta-analysis of GERA Latinos, East Asians, and African Americans; independent
related quantitative traits in a subset of GERA; and in the UK Biobank self-report data. Of
note, we were unable to replicate any of the previously-described suggestive GWAS loci. How-
ever, we additionally found two SNPs associated with ARHI when specifically looking at vari-
ants in exons in previously-identifiedMendelian hearing loss genes. Finally, we estimated only
modest genome-wide heritability.
The indel rs58389158 on 22q13.1 that we identified to be associated with ARHI has a poten-
tial functionalmechanism through the gene TRIOBP/RP1-37E16.12, a filamentous actin (F-
actin) binding protein that is associated with the TRIO guanine nucleotide exchange factor and
regulates actin cytoskeleton organization. Nonsense, missense, and frameshift mutations in
this gene have been previously associated with recessive prelingual nonsyndromic hearing loss
[23–27], and it has been shown to be expressed in 11 human tissues in the short isoform and 3
in the long isoform, including expression in the cochlea [26], where its potential role in hearing
loss has been described in detail. The SNP is 5773bp 3’ of exon 7 in the long NM_001039141
isoform (24 exons, exon 7 the largest at 3319bp) and 1021bp 5’ of exon 8 (which is 115bp) of
TRIOBP (and upstream of the other shorter two isoforms NM_007032, 14 exons, and
NM_13862, 8 exons). It is highly correlated with rs5756795 (r2 = 0.96/0.97/0.97/0.94 in 1000
Genomes European/Admixed American/East Asian/African populations, respectively; b37
position = 38,122,122, 6,091bp from rs58389158), a missense variant in exon 7 (TTC to CTC, F
[Phe] to L [Leu]) that was also genome-wide significant in GERA non-Hispanic whites
(p = 2.8x10-9). According to SeattleSeqAnnotation v138 [28], the rs5756795 variant is pre-
dicted to be not likely deleterious (PolyPhen2 probability of being damaging 0.006, predicted
benign [29]; grantham score = 22, range from 5–215, higher more deleterious [30]), while the
Combined Annotation Dependent Depletion (CADD) score [31] was borderline (13.5, scores
greater than 10 indicate that the variant is predicted to be among the 10%most deleterious sub-
stitutions in the human genome); the variant also showed high conservation scores (Phast-
Cons = 0.996, range from 0–1, with higher beingmore conserved [32]; Genomic Evolutionary
Rate Profiling (GERP) score 2.89, ranges from -12.3 to 6.17, with 6.17 beingmost conserved
[33]). There is potential that the missense variant itself may be affecting the protein produced,
or the regulatory region around it may be affecting the transcript produced.While numerous
mutations in TRIOBP have been associated with hearing loss, neither of these variants has
been previously reported to be associated with hearing loss.
This GWAS also identified rs4932196 on chromosome 15. The mechanism through which
this SNP leads to hearing loss is unclear, but 2 genes in the vicinity of rs4932196 and/or corre-
lated with it (r2>0.80) could be relevant. The SNP is 52kb 3’ of gene ISG20, and 685kb 5’ of
ACAN, which codes for Aggrecan. Aggrecan is a major component of the extracellularmatrix of
cartilaginous tissues while the ISG20 protein is involved in pathways such as interferon signaling.
To identify potential mechanisms in humans of rs4932196, we assessed human tissue
expression results from the ENCODE project through Haploreg v4.1 [34], which includes
many different human tissue types, but no auditory tissues. The database showed that the SNP
(or those highly correlated with it) lies in a region that is transcriptionally active; it is within
DNAse hypersensitivity sites that are transcriptionally active in 8 tissues, and it affects the
binding motifs for 38 transcription factors. The database also suggested that the SNP may be in
a regulatory region–it is within enhancer histone marks for 16 different tissues. Lastly, the data-
base showed that the SNP likely affects ISG20 or ACAN expression. The expression Quantita-
tive Trait Locus (eQTL) analysis, which tests for an association of a SNP with the expression of
genes, showed that rs4932196 and the SNPs highly correlated around it are associated with
expression of both ISG20 (p ranges from 0.0013 to 6.7x10-8 from whole blood) and ACAN (p
ranges from 2.9x10-5 to 9.2x10-6 in GTex 2015 cells transformed from fibroblasts, a cell type
Genome-Wide Study of Age-Related Hearing Impairment
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that synthesizes the extracellularmatrix and collagen); Haploreg includes eQTL results from
GTex, GUEVADIS, and 10 other studies. These results do not indicate whether ISG20 or
ACAN is the more likely mechanistic explanation for the association with ARHI.
Since human auditory tissue data were unavailable, we looked at the expression of the two
genes in mouse auditory tissue using the Shared Harvard Inner Ear Database (SHIELD) [35].
Data frommice show that ACAN is expressed in mouse auditory tissue. Scheffer et al. looked at
the expression of the genes in the cochlea and utricle at several mouse developmental stages
[36]. The highest estimated expression was in the P7 developmental stage in the cochlear non-
hair cells. The overall expression in the cochlear hair cells was significantly different from that
in the non-hair cells (FDR = 0.00012, fold change = 0.03, S4 Fig). ACAN expression was higher
in the cochlea than in the utricle, but the difference was not significant (FDR = 0.37, fold
change = 6.2). Also, postnatal expression was higher (but not significantly) than embryonic
expression (FDR = 0.31, fold change = 6.7). Liu et al. tested for gene expression differences
between cochlear outer and inner hair cells in P25 to P30 mice and did not find a significant
difference for ACAN (FDR = 0.948, fold change = 0.99) [37]. Lastly, Shin et al. tested for differ-
ential expression between the spiral and vestibular ganglia at several developmental times [38]
and found no evidence for any expression differences (S4 Fig).
Mouse studies also support a role for ISG20 in mouse auditory tissue. Expression results for
the ISG20 gene were similar to those for ACAN, except that the strongest expression was esti-
mated to be in the utricle (S4 Fig). There were no significant expression differences between
hair cells and non-hair cells (FDR = 0.15, fold change = 0.17), cochlea and utricle (FDR = 0.35,
fold change = 0.21, utricle higher than cochlea), postnatal and embryonic (FDR = 0.51, fold
change = 4.63), or cochlear outer and inner hair cells (FDR = 0.56, fold change 1.2). Finally,
spiral and vestibular ganglia showed no significant differential expression of ISG20. The mouse
expression results provide perhaps slightly more support for ACAN than ISG20 as the gene
near rs4932196 that is associated with hearing loss.
Because of our TRIOBP results, we also looked at knownMendelian hearing loss genes, par-
ticularly the exons, and discovered two SNPs, which also had evidence of replication. The first
SNP, rs2877561 is a synonymous mutation in exon 2 in ILDR1, a gene encoding an immuno-
globulin-like domain containing protein. Previous work has found 10 different homozygous
mutations in the gene that cause autosomal recessive prelingual nonsyndromic moderate to
profound hearing loss, that was more pronounced at higher frequencies; one of these includes
a 35bp deletion at the exon 2 splice acceptor site [39,40]. The ILDR1 gene was also shown to be
expressed in the cochlea in mice, at lower to intermediate levels in hair cells, and higher levels
in some supporting cells [39]. The SNP rs2877561 had high conservation scores for a nucleo-
tide change (PhastCons 0.996, GREP 3.650, see Discussion of these scores above), but a very
low CADD score (0.383, see Discussion above). The second SNP, rs9493627, is a missense
mutation (GGC to AGC, G [Gly] to S [Ser]) at position 25 in exon 11 of EYA4, a gene that
encodes a transcriptional activator, interacting with other protein families to regulate early
development. Previous mutations in the gene have been shown to cause postlingual progressive
autosomal dominant hearing loss, resulting in stable flat sensorineural deafness without the
influence of presbycusis [41]. Two mutations causing premature stop codons were found in
exon 12 with a single individual having a mutation in exon 11 at position 1270, very close to
rs9493627 at position 1287. The variant rs9493627 itself had no Polyphen evidence of being
damaging (0.969), had high conservation scores (PhastCons 1.000 and GERP score 5.490), a
Grantham score of 56, and a CADD score of 35.0 (see Discussion of these scores above).
Our discovery of these two additional SNPs in exons of known hearing loss genes suggests
potential regions of the genome to focus on for finding additional SNPs associatedwith ARHI. It
also provides more evidence suggesting a potentially similar etiology for ARHI as hearing loss.
Genome-Wide Study of Age-Related Hearing Impairment
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The use of a large cohort with comprehensive, longitudinal EHRs provided a much larger
sample size than has been previously analyzed for ARHI, albeit with a slightly different pheno-
type than those based on hearing frequency thresholds. The advantage of such an approach is
the large numbers of individuals that can be analyzed, while the disadvantage is that the cohort
is not specifically characterized for hearing loss, but has to be inferred indirectly. Because of
late and insidious onset of age-related hearing loss, and the fact that our primary analysis was
based on ICD9 diagnosis, we expect that the ARHI effect size estimates may be biased down-
ward and the power to detect novel loci diminished due to misclassification of individuals who
did not seek treatment. It likely also dampened our genome-wide heritability estimate. How-
ever, to support the validity of our phenotype, we did see large differences in the quantitative
measures SRT and SDS between cases and controls. Unfortunately we did not have data on
noise exposure except for what was available in the audiologist notes in the reduced cohort–
again, another limitation of a dataset not specifically designed to capture data regarding hear-
ing loss.
The degree to which the two genome-wide significant SNPs were replicated in the other
GERA race/ethnicity groups, the other GERA quantitative phenotypes, and the UK Biobank
data, varied. Reasons for weaker associations in the other GERA race/ethnicity groups include
both different LD structures as well as a much smaller sample size. The latter is also a reason
for reduced power of analysis of the related quantitative GERA phenotypes. Finally, the UK
Biobank was based on a self-reported phenotype largely at one cross-sectional survey, as
opposed to our diagnosis that required having two ICD-9 diagnostic codes and an age at diag-
nosis. In addition, the UK Biobank individuals were at least a decade younger, on average, yet,
surprisingly, had a higher proportion of cases, also indicating some inconsistency between the
UK Biobank and KP phenotypes.
Our study did not replicate any previously reported sub-genome-wide significant findings
seen in prior GWAS studies; this could be due to power or slightly different phenotypes, or
potentially because these previously reported analyses were based on sub-genome-wide-signifi-
cant loci rather than genome-wide significant loci. Although the Glutamate ReceptorMetabo-
tropic 7 (GRM7) locus has shown some replication [3], it has failed to do so in more recent
results [14]. Our ARHI phenotype was also slightly different from the quantitative phenotypes
used in most of these studies, which were calculated from principal components of several
hearing frequency thresholds (i.e., the minimum loudness at which a hearing frequency can be
heard, repeated for several frequencies, which constitute the points shown on an audiogram).
In summary, we have utilized a general cohort with a large number of middle-aged and
older individuals and clinical data from EHRs to discover four loci associated with ARHI. One
of these SNPs may be a missense variant in a known hearing loss gene. The second is close to
two potential candidate genes through which it may exert its effect. The other two SNPs were
exon variants discovered in known hearing loss genes. Studies are ongoing on these SNPS to
determine how they interact with their respective surrounding candidate genes. Studies of
other large genotyped cohorts with searchable EHR records, as well as the use of more precise
phenotypes (e.g., scanned audiograms on a subset of the cohort) will continue to improve our
understanding of the genetics underlying ARHI.
Materials and Methods
Participants and phenotype
Our primary analysis used non-Hispanic white individuals from the RPGEHGERA cohort,
which has been previously described [18,19]. Hearing tests are part of routine care in the Kaiser
Permanente health care system, and the majority of audiologist record notes are stored in the
Genome-Wide Study of Age-Related Hearing Impairment
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EHR, although some scan in handwritten notes. The audiograms themselves are not coded
directly into the EHR numerically, and instead may be scanned images. For the current analy-
sis, our primary phenotype was constructed by querying the EHR for ARHI related phenotypes
from 01/1996-12/2014. A total of 16,123 unique individuals had at least 1 diagnosis of the
ICD-9 codes 388.01 (presbycusis, 137 recorded diagnoses on 107 unique individuals), 389.12
(bilateral neural hearing loss, 135 recorded diagnoses on 63 unique individuals), and 389.19
(bilateral sensorineural hearing loss, 52,711 recorded diagnoses on 16,045 unique individuals).
To help ensure the validity of cases and eliminate any potential errors in the EHR, we required
ARHI cases to have at least 2 ICD-9 entries of any of these three codes, resulting in 8,285 indi-
viduals.We also ran our GWAS with a phenotype definition of at least one diagnosis; this
slightly dampened our results. After excluding a small number of individuals with any single
ICD-9 code for ear damage of transient ischemic deafness (388.02), noise effects on inner ear
unspecified (388.10), acoustic trauma (explosive) to ear (388.11), noise-induced hearing loss
(388.12), sudden hearing loss unspecified (388.2), and abnormal auditory perception unspeci-
fied (388.40), 8,111 individuals remained. For the controls, we began with the 86,790 individu-
als who were free of any of the ICD-9 codes used to identify cases.We further excluded
individuals with any single ICD-9 368.XX (other disorders of the ear) or other 388.XX (hearing
loss) code, resulting in 61,811 individuals. After excluding those who had a Current Procedural
Terminology (CPT) code for hearing aids, 61,689 individuals remained. Finally, after excluding
at random genetic first-degree relatives identified using King robust [42], we were left with a
total of 7,569/58,652 cases/controls in GERA.We used the 6,527/45,882 GERA non-Hispanic
white cases/controls in our discovery cohort. Note that we also required 2 or more ICD-9
codes for diagnosis of the phenotypes we used as covariates–hypertension 401.XX and 997.91,
osteoporosis 733.XX, and diabetes 250.XX, traits which have been shown to be potentially asso-
ciated with ARHI.
We also examined a secondary set of hearing related phenotypes on a much smaller subset
of the cohort that had audiologist notes in the EHR data (the majority from cases). Speech Dis-
crimination Scores (SDS), or the percentage of words that can be recognizedwhen speech is
loud enough to be heard comfortably, and Speech RecognitionThreshold (SRT) measure-
ments, or the decibel level at which an individual can understand 50% of spoken words tested,
were available on 4,903 unrelated GERA individuals (9,454 total measurements, as some indi-
viduals had multiple independent measurements at different times) whose EHR included notes
taken by their audiologist. Most electronic notes followed a specific template, making extract-
ing certain phenotype information easier. For our outcome, we extracted both SDS and SRT
scores, averaging the left and right ear scores. We also attempted to quantify a crude noise
exposure history indicator variable based on recorded text from audiologist notes regarding
potential noise exposure occupations and activities from these notes (only available on the
same subset, so only SDS and SRT were adjusted for noise). To identify potential noise expo-
sure words that had been recorded in each individual’s notes, we began by constructing an
exhaustive list of all possible words that were in these notes. We identified a total of 31,825
unique words from the combined set of all individuals’ notes. This was a short enough list that
we could simply manually inspect each of these unique words to determine all noise exposure
variables given by patients. Once all possible noise exposure variables were identified, we
searched for either presence of the noise variable vs. absence of each of the noise exposure vari-
ables in the text (e.g., patient denies vs. patient reports). If a noise variable was identified, then
that individual was assumed to have a history of noise exposure. If noise variables were absent
in the audiologist notes, we assumed the individual had no history of noise exposure.
The Kaiser Permanente Northern California Institutional ReviewBoard (study #CN-13-
1643-H) and the University of California San Francisco Human Research Protection Program
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Committee on Human Research (study #13–12476) approved this research project. All partici-
pants provided written informed consent.
Genotyping, quality control, and imputation
A total of 110,266 GERA cohort individuals were genotyped on one of four race/ethnicity-spe-
cific AffymetrixAxiom arrays optimized for individuals of European (EUR), Latino (LAT), East
Asian (EAS), and African American (AFR) race/ethnicity [43,44]. Quality control was performed
on an array-wise basis, which has been described [19]. Briefly, 102,998 individuals passedQC in
the first pass genotyping round with individual DishQC (DQC)>82%and individual CR>97%.
A total of 85 individuals failed X chromosome heterozygosity tests (male20%, female80%),
leaving 102,913 individuals (step added not in [19]). Genotypes were filtered by package (plates
of 96 samples were grouped by similar assay conditions into 58 packages), retaining SNPs with
CR90%, variance ratio31, and male/female frequency differences15% [19]. SNPs with poor
duplicate concordance were removed, and those with overall call rate<60% were removed, as
described in [19]. Here, we additionally required a stricter array per-SNP call-rate of 90%, result-
ing in 665,046 (EUR), 775,597 (LAT), 702,405 (EAS), and 863,961 (AFR) SNPs, respectively.
Finally, to avoid SNPs with lowminor allele counts within each race/ethnicity group, we excluded
SNPs with a minor allele frequency (MAF) less than 0.0015 (EUR), 0.02 (LAT), 0.025 (EAS), and
0.065 (AFR), leaving a total number of SNPS of 659,803 (EUR), 648,979 (LAT), 588,493 (EAS),
543,158 (AFR), respectively, and a total of 1,188,134 unique genotyped SNPs available for analy-
sis across all race/ethnicity groups.
Imputation was also performed on an array-wise basis, and before the MAF cutoff described
above was applied. Genotypes were first pre-phased with Shape-it v2.r72719 [45]. We then
imputed 31,085,734 variants from the 1000 Genomes Project (phase I integrated release,
March 2012, with Aug 2012 chromosome X update, with singletons removed) as a cosmopoli-
tan reference panel with Impute2 v2.30 [46–48]. The estimated quality control metric used in
this study, rinfo2, is the info metric from Impute2, which gives an estimate of the correlation of
the imputed genotype to the true genotype [49]. SNPs that did not impute with high quality
(rinfo2<0.8) were removed. The rinfo2 and MAF exclusion criteria for the imputed SNPs resulted
in a final number of SNPs of 9,469,183 (EUR), 8,090,486 (LAT), 6,517,021 (EAS), and
7,829,026 (AFR), and a total of 11,910,003 unique imputed SNPs available for analysis across
all race/ethnicity groups.
GWAS analysis and covariate adjustment
For our discovery cohort primary analysis, we used the GERA non-Hispanic whites, employing
the conventional genome-wide significance level of 5x10-8. Data from each SNP was modeled
using additive dosages, which account for the uncertainty in imputation [50]. We ran a logistic
regression on ARHI diagnosis, including covariates for age (at diagnosis for cases, and at last
follow-up for controls), diabetes, hypertension, and osteoporosis, and also included sex and the
first ten ancestry PCs for non-Hispanic whites to adjust for genetic ancestry/population stratifi-
cation; the PC analysis has been previously described [18]. For computational efficiencywe
first ran a logistic model including all covariates except the SNP, and collapsed them into a sin-
gle covariate for each individual as the sum of the coefficients times each of the covariates for
each individual, and then ran a logisticmodel including only the SNP and the collapsed covari-
ate. Including a single covariate with the SNP genotype reduced the computing time, without
loss of accuracy because the SNP effects are quite modest and have virtually no influence on
the other covariates. We further confirmed that our top hits showed no appreciable difference
fit this way versus the full model (the odds ratio estimates were identical).
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For the secondary phenotypes available on a subset of the cohort, we transformed the quan-
titative phenotypes by taking the square root of SRT, and log(100—SDS + 1) to make them
more normally distributed.We ran a mixed model regression analysis on each of the trans-
formed SDS and transformed SRT values (to account for repeated measures), including the
same covariates as described above in the analysis of ARHI, as well as noise exposure.We ana-
lyzed the transformed SDS and SRT phenotypes separately in ARHI cases and controls, and
then meta-analyzed them, to construct a test that was independent of the ARHI test.
Replication in GERA Latinos, East Asians, African Americans, and UK
Biobank individuals
To determine whether the novel SNPs identified in GERA non-Hispanic whites constituted
replicable findings, we evaluated the SNPs in 481/5,215 GERA case/control Latinos, 398/5,040
GERA East Asians, and 146/2,133 GERAAfrican Americans (there were an additional 17
South Asian cases, too few to analyze), in addition to 30,802/78,586 self-reported case/control
individuals from the initial preliminary release of the UK Biobank; complete details of this
cohort are available at www.biobank.ac.uk, and the cohort has been previously described [51].
For the SRT and SDS phenotypes, there were 298 Latinos, 249 East Asians, and 125 African
Americans available for analysis. For the three GERAminority groups, we used the analysis
methods described above, but adjusting for the first six genetic ancestry PCs in each of the
three minority groups. A strict Bonferroni α-level for two tests is 0.05/2 = 0.025. In addition, all
replication tests are based on a single direction alternative hypothesis (i.e., the effect size in the
same direction as in the discovery), therefore we report one-sided P-values.
Cases for the UK Biobank were identified by a self-reported yes to the question “Do you have
any difficultywith your hearing?” (variable 2247.0/1/2.0) and a yes to the question “Do you find
it difficult to follow a conversation if there is background noise (such as a TV, radio, children
playing)” (2257.0–2.0). Individuals who reported being completely deaf were excluded. Controls
were identified as those answering no to both of the previous hearing questions, as well as not
reporting having a hearing aid (3393.0–2.0). Age was reported as the age at the time of survey (as
opposed to age of diagnosis, which was unavailable; cases average age = 58.8, sd = 7.4; control
average age = 55.6, sd = 8.1). Analysis was based on a logistic regressionmodel including the
SNP as the dependent variable and adjusting for sex (22001.0.0), hypertension (defined as aver-
age of SBP140 or DBP90; variables 93.0–2.0–1, 94.0–2.0–1, 4079.0–2.0/1, 4080.0–2.0–1), self-
reported diabetes (2443.0–2.0), self-reported occupational/loudmusic noise exposure (4825.0–
2.0, 4836.0–2.0), and 10 ancestry PCs. First-degree relatives identified by King robust [42] were
randomly removed. Individuals were further restricted to those whose self-reported ancestry
(21000.0–2.0) was from any white group and whose global genetic ancestry PC1<50 and
PC2<50, where these PCs were calculated from the entire cohort (22009.0.1–2). This resulted in
a total of 30,802 cases and 78,586 controls. We then re-calculated ancestry PCs in this group
using a set of 371,038 very high quality SNPs (call rate>99%, MAF>1%, and LD filtered so no
two SNPs had r2>0.5) and using 50,000 random individuals with the remainder projected, as
describedpreviously [18].
Replication analysis of previously described suggestive Loci
We also tested 58 previously described sub-threshold suggestive SNPs for replication in this
study. The phenotypes of three studies have been based on PCs of several hearing frequency
thresholds (3,417 European ancestry individuals in [15], 2,161 Belgian individuals [14], and
352 Finnish Saami individuals [16]). We included in this analysis any SNPs reported in their
supplemental material with P<1x10-5. We also included the GRM7 SNPs from the study of
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846 cases and 846 controls [3]. For the replication p-value threshold we used 0.05 divided by
the number of SNPs compared (α = 0.00086), and we also report any nominal associations
(p<0.05).
ARHI associations at previously identified hearing loss genes
We examined genetic variation at 132 known hearing loss genes for associationwith ARHI [21]
using our GWAS results at reduced significance thresholds to reflect the proportion of the
genome being tested to account for potential lack of power in these regions. For each of the
genes, we looked separately at exonic SNPs, specifically non-synonymous and synonymous cod-
ing changes, and then SNPs that were eQTLs for that gene in any GTeX tissue (no human audi-
tory tissues available) [22]. We looked ±50Kb of each gene, or up to any eQTL. This led to
414,466 imputed SNPs, or 4.7% of the genome (the usual genome-wide correction is for 1 million
tests, despite more SNPs, to correct for correlation, so a Bonferroni correction for percentage of
the genome would be 0.05/47000 = 1.1x10-5, which no SNPs met).We further looked into the
253 nonsynonymous exon changes; to determine the correction factor for multiple testing, we
decomposed the correlationmatrix of these SNPs (based on pairwiseLD r-square values) into
theM eigenvalues λ1, . . ., λM, and solved for M such that (∑m = 1,. . .,M λm)/(∑m = 1,. . .,M λm c,
for c = 0.95 [52], which has additionally shown to performwell [53]. For the nonsynonymous
changes we found that M = 202, for a Bonferroni correction of α = 0.00025. For the 909 synony-
mous changes, we found that M = 536, for a Bonferroni correction of α = 9.3x10-5.
Heritability from all GWAS SNPs and variance explained by ARHI
associated SNPs
We estimated the additive array heritability of ARHI using Genome-wideComplex Trait Anal-
ysis (GCTA) v1.24 [54]. Since array heritability estimates may potentially be more sensitive to
artifacts than GWAS results [55], we restricted our analysis to the largest group of individuals,
non-Hispanic whites who had been run on the same reagent kit and type of microarray [19],
and imposed the following extra filters on the autosomal SNPs: Hardy-Weinberg equilibrium
test p<0.05 (in controls), significant differences in case-control missing p<0.05, and absolute
MAF differences>0.15 when compared with the 1000 Genomes Project. Finally, we also
employed an LD filter so that no two neighboring pairwise SNPs had r2>0.8, leaving 427,157
SNPs. In all analyses we further removed individuals outside 5 standard deviations of the first
two genetic ancestry PCs, and also removed individuals so that no two remaining individuals
had an estimated kinship>0.025 in a manner that maximized the remaining sample size, using
PLINK v1.9 [56]. The remaining sample had a total of 4,603 cases and 34,136 controls. The
heritability estimate depends on the prevalence of the disease through a liability threshold
model; we used the prevalence of ARHI in the non-Hispanic whites in our cohort of 12.5%,
and explored several other estimates (we note this is an age-averaged threshold). In addition,
we estimated the variance explained by the ARHI associated SNPs [57].
Supporting Information
S1 Table. Results at previously-identified GWAS sub-threshold SNPs in GERA. Previously-
identified results were large based on hearing threshold principal components, which are not
directly comparable to the results here.
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S1 Fig. Q-Q plot for GERA non-Hispanic whites. Previously-identified sub-threshold SNPs
are separated from the rest of the SNPs (dark green is the SNP itself, light green is within
Genome-Wide Study of Age-Related Hearing Impairment
PLOS Genetics | DOI:10.1371/journal.pgen.1006371 October 20, 2016 16 / 20
0.5Mb of the SNP). Typed SNPs are circles, imputed are triangles.
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S2 Fig. Results at previously-identifiedMendelian hearing loss genes. Results at previously-
identifiedMendelian hearing loss genes. SNPs between the start and end of the gene colored in
blue, non-synonymous coding changes in red, other exon next steps in orange, eQTL SNPs in
green.
(PDF)
S3 Fig. Age of onset distributions in non-Hispanic white cases.Age of onset distributions for
the ARHI variants in GERA non-Hispanic whites, based on residuals and normalized to a
female without diabetes, hypertension, or osteoporosis.
(PDF)
S4 Fig. Mouse tissue expression of ACAN and ISG20. FACS, fluorescence-activated cell sort-
ing hair cells. E represents embryonic tissue, P postnatal. Numbers represent numbers of days.
(PDF)
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